biggestjackpotever| Financial report express: Wanze's net profit for the first quarter of 2024 was 65.7682 million yuan

editor|
30

On April 29th, Wanze shares (000534) (000534), an A-share listed company, released its first-quarter results report in 2024. Of which, the net profit is 6576.Biggestjackpotever820,000 yuan, an increase of 12.41% over the same period last year.

According to the comprehensive operation and follow-up analysis of more than 1200 financial indicators of its financial data in the current period and the past five years according to the financial diagnosis model of flush (300033), Wanze shares are in good financial condition in the past five years. Specifically, the growth ability, profitability is excellent, operating ability is good, asset quality, cash flow is general.

The net profit was 65.7682 million yuan, up 12.41% from the same period last year.

In terms of revenue and profit, the company achieved total operating income of 290 million yuan in the reporting period, an increase of 3.20% over the same period last year, and a net profit of 65.7682 million yuan, an increase of 12.41% over the same period last year, with basic earnings per share of 0.13 yuan.

In terms of assets, during the reporting period, the total assets at the end of the period were 3.251 billion yuan and the accounts receivable were 390 million yuan.BiggestjackpoteverIn terms of cash flow, the net cash flow generated by business activities is-16.674 million yuan, and the cash received from the sale of goods and services is 221 million yuan.

There are three financial highlights.

According to the relevant financial information announced by Wanze shares, there are three financial bright spots in the company, as follows:

The average rate of return on net assets is 11.15%, and the company's profitability is outstanding. The average year-on-year growth rate of net profit is 31.43%, and the growth of the company is outstanding. Inventory turnover the average inventory turnover rate is 1.36 (times / year), and the inventory liquidity is very strong.

There are two financial risks

biggestjackpotever| Financial report express: Wanze's net profit for the first quarter of 2024 was 65.7682 million yuan

According to the relevant financial information announced by Wanze shares, there are two financial risks in the company, as follows:

According to the type of indicators, the proportion of interest-paying debt is 41.19%, and there is a lot of pressure on debt repayment. The quick debt repayment ratio is 0.80, and the short-term solvency is very weak.

Overall, Wanze shares are in good financial condition, with a current total score of 3.08, ranking high among 56 companies in the biological products industry. Specifically, the growth ability, profitability is excellent, operating ability is good, asset quality, cash flow is general.

The scores of the indicators are as follows:

Index type previous period score ranking evaluation growth ability 4.644.0212 outstanding profitability 3.664.0212 excellent operating ability 4.643.5717 good asset quality 2.321.6140 general cash flow 2.681.1644 general solvency 1.250.8048 lower total score 3.583.0815

On the large model of financial diagnosis of flush

Flush (300033) Financial diagnosis model calculates the company's financial scores, highlights and risks based on the company's latest and previous financial data and industry conditions, reflecting the company's disclosed financial position, but not a forecast of the future financial position. The financial score range is 0-5. The higher the score, the better the financial situation and the greater the value of the medium-and long-term investment. In the financial highlights and risk reviews, the five-year average of the indicators related to the "average" keyword, and the latest reporting period data without the "average" keyword. All the above information is based on artificial intelligence algorithm, for reference only, does not represent flush financial point of view, investors operate accordingly, at their own risk.

Learn more about the company's stock diagnostic information >